Farxiga, Forxiga, Diabetes, Chronic Heart Failure, SGLT2 inhibitors, Chronic Kidney diseases, Farxiga price, Farxiga cost, Forxiga Cost, Forxiga price, Forxiga approval

Farxiga/Forxiga: Drug for Diabetes, Heart Failure and Kidney Disease

Anika Sharma

Farxiga is a brand name in the United States and Forxiga is the brand name in Europe and other countries. ...

Forxiga, Chronic heart failure, Dapagliflozin, FDA approval, National Medical Products Administration

Forxiga Receives Green Light in China to Mitigate Cardiovascular Mortality and Hospitalization in Adults Battling Symptomatic Chronic Heart Failure

Anika Sharma

China’s National Medical Products Administration (NMPA) has granted approval to Forxiga (dapagliflozin) as a groundbreaking solution in the fight against ...

EU Approves Jardiance for CKD: Forxiga Faces Tough Rival

Jardiance Receives EU Approval for Treating Chronic Kidney Disease (CKD), Posing a Strong Challenge to Forxiga

SG Tylor

Source – Boehringer Ingelheim The European Union has granted approval for Boehringer Ingelheim and Eli Lilly’s SGLT2 inhibitor, Jardiance (empagliflozin), ...